Concepedia

Publication | Open Access

MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance

DOIFull Paper Access

34

Citations

29

References

2013

Year

Amanda K. Paulson, Erik S. Linklater, Bree D. Berghuis, Colleen A. App, Leon D. Oostendorp, Jayne E. Paulson, Jane Pettinga, Marianne K. Melnik, George F. Vande Woude, Carrie R. Graveel
Molecular Cancer Research

Abstract

ERBB2(+) breast cancers with MET(+)/ERBB2(+) subpopulations may have an innate resistance to ERBB2 inhibition and may benefit from combined MET and ERBB2 inhibition.

References

YearCitations

Page 1